Biomarkers for prostate cancer: prostate-specific antigen and beyond
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers for prostate cancer: prostate-specific antigen and beyond
Authors
Keywords
-
Journal
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
Volume -, Issue -, Pages -
Publisher
Walter de Gruyter GmbH
Online
2019-11-12
DOI
10.1515/cclm-2019-0693
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
- (2019) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study
- (2019) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
- (2019) Jonas Hugosson et al. EUROPEAN UROLOGY
- Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019
- (2019) Giorgio Gandaglia et al. EUROPEAN UROLOGY
- Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening
- (2018) Robert A. Smith et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Management of Men with Prostate-specific Antigen Failure After Prostate Radiotherapy: The Case Against Early Androgen Deprivation
- (2018) Douglas Brand et al. EUROPEAN UROLOGY
- Early Androgen Deprivation Therapy Improves Survival, But How Do We Determine in Whom?
- (2018) Mark Frydenberg et al. EUROPEAN UROLOGY
- Time for a “Radical” Change to Active Surveillance for Prostate Cancer?
- (2018) Jenny L. Donovan et al. EUROPEAN UROLOGY
- Clinical and Genomic Characterization of Low–Prostate-specific Antigen, High-grade Prostate Cancer
- (2018) Brandon A. Mahal et al. EUROPEAN UROLOGY
- Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
- (2018) Silke Gillessen et al. EUROPEAN UROLOGY
- Prostate-Specific Antigen–Based Screening for Prostate Cancer
- (2018) Joshua J. Fenton et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality
- (2018) Richard M. Martin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel
- (2018) Lauren C. Harshman et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimizing Anticancer Therapy in Metastatic Non-Castrate Prostate Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Michael J. Morris et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials
- (2018) Glenn Heller et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options
- (2018) Martin G. Sanda et al. JOURNAL OF UROLOGY
- Value of free/total prostate-specific antigen (f/t PSA) ratios for prostate cancer detection in patients with total serum prostate-specific antigen between 4 and 10 ng/mL
- (2018) Yan Huang et al. MEDICINE
- Clinical implications of PTEN loss in prostate cancer
- (2018) Tamara Jamaspishvili et al. Nature Reviews Urology
- Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
- (2018) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
- (2018) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Results of Prostate Cancer Screening in a Unique Cohort at 19 yr of Follow-up
- (2018) Daniël F. Osses et al. EUROPEAN UROLOGY
- Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review
- (2018) Thomas Van den Broeck et al. EUROPEAN UROLOGY
- Evaluation of New Tests and Interventions for Prostate Cancer Management: A Systematic Review
- (2018) Ghadeer Olleik et al. Journal of the National Comprehensive Cancer Network
- Re: Reevaluating PSA Testing Rates in the PLCO Trial
- (2017) Peter Albers EUROPEAN UROLOGY
- Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators
- (2017) Lei Wei et al. EUROPEAN UROLOGY
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
- (2017) Philip Cornford et al. EUROPEAN UROLOGY
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2017) Nicolas Mottet et al. EUROPEAN UROLOGY
- Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
- (2017) Emmanuel S. Antonarakis et al. JOURNAL OF CLINICAL ONCOLOGY
- Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic Disease
- (2017) Daniel E. Spratt et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
- (2017) Hashim U Ahmed et al. LANCET
- Prostate Cancer Screening — A Perspective on the Current State of the Evidence
- (2017) Paul F. Pinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysis
- (2017) Alejandro Berlin et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment
- (2016) Scott A. Tomlins et al. EUROPEAN UROLOGY
- Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score
- (2016) Leander Van Neste et al. EUROPEAN UROLOGY
- A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort
- (2016) Katharina Braun et al. EUROPEAN UROLOGY
- Prostate-Specific Antigen Screening: Time to Change the Dominant Forces on the Pendulum
- (2016) Jonathan E. Shoag et al. JOURNAL OF CLINICAL ONCOLOGY
- Evidence-Based Versus Personalized Prostate Cancer Screening: Using Baseline Prostate-Specific Antigen Measurements to Individualize Screening
- (2016) Stacy Loeb JOURNAL OF CLINICAL ONCOLOGY
- Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
- (2016) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
- (2016) Shuang G Zhao et al. LANCET ONCOLOGY
- Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
- (2016) Jenny L. Donovan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening
- (2016) Andrew J. Vickers et al. UROLOGY
- The Prostate Health Index adds predictive value to multi-parametric MRI in detecting significant prostate cancers in a repeat biopsy population
- (2016) V. J. Gnanapragasam et al. Scientific Reports
- Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis
- (2016) Yong Cui et al. Scientific Reports
- Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer
- (2016) Alexander W. Wyatt et al. JAMA Oncology
- Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
- (2015) J Cuzick et al. BRITISH JOURNAL OF CANCER
- Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer
- (2015) P. Blume-Jensen et al. CLINICAL CANCER RESEARCH
- A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer
- (2015) Jennifer Cullen et al. EUROPEAN UROLOGY
- PCA3 in prostate cancer and tumor aggressiveness detection on 407 high-risk patients: a National Cancer Institute experience
- (2015) Roberta Merola et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Multicenter Evaluation of the Prostate Health Index to Detect Aggressive Prostate Cancer in Biopsy Naïve Men
- (2015) Claire de la Calle et al. JOURNAL OF UROLOGY
- The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer
- (2015) Stacy Loeb et al. JOURNAL OF UROLOGY
- Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study
- (2015) Henrik Grönberg et al. LANCET ONCOLOGY
- Urinary PCA3 and TMPRSS2:ERG reduce the need for repeat biopsy
- (2015) Peter Sidaway Nature Reviews Urology
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preoperative prostate health index is an independent predictor of early biochemical recurrence after radical prostatectomy: Results from a prospective single-center study
- (2015) Giovanni Lughezzani et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis
- (2014) K. S. Louie et al. ANNALS OF ONCOLOGY
- A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling
- (2014) Eric A. Klein et al. EUROPEAN UROLOGY
- Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer?
- (2014) John T. Wei et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies
- (2014) Alan W. Partin et al. JOURNAL OF UROLOGY
- Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
- (2014) Fritz H Schröder et al. LANCET
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial
- (2013) Paul F. Pinsky et al. BJU INTERNATIONAL
- The utility of prostate-specific antigen in the management of advanced prostate cancer
- (2013) E. David Crawford et al. BJU INTERNATIONAL
- Serum Isoform [−2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2–10 ng/ml: A Multicentric European Study
- (2013) Massimo Lazzeri et al. EUROPEAN UROLOGY
- Head-to-Head Comparison of Prostate Health Index and Urinary PCA3 for Predicting Cancer at Initial or Repeat Biopsy
- (2013) Vincenzo Scattoni et al. JOURNAL OF UROLOGY
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostate cancer screening and the management of clinically localized disease
- (2013) T. J. Wilt et al. BMJ-British Medical Journal
- Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer
- (2012) Meelan Bul et al. BJU INTERNATIONAL
- Prostate-specific antigen kinetics as a surrogate endpoint in clinical trials of metastatic castration-resistant prostate cancer: A review
- (2012) G. Colloca CANCER TREATMENT REVIEWS
- Multicenter Evaluation of [-2]Proprostate-Specific Antigen and the Prostate Health Index for Detecting Prostate Cancer
- (2012) C. Stephan et al. CLINICAL CHEMISTRY
- Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
- (2012) G. L. Andriole et al. JNCI-Journal of the National Cancer Institute
- A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy
- (2011) Marco Auprich et al. BJU INTERNATIONAL
- A Panel of Kallikrein Marker Predicts Prostate Cancer in a Large, Population-Based Cohort Followed for 15 Years without Screening
- (2011) A. J. Vickers et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- False-positive screening results in the European randomized study of screening for prostate cancer
- (2011) Tuomas P. Kilpeläinen et al. EUROPEAN JOURNAL OF CANCER
- Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection
- (2010) Flip H. Jansen et al. EUROPEAN UROLOGY
- Critical Assessment of Preoperative Urinary Prostate Cancer Antigen 3 on the Accuracy of Prostate Cancer Staging
- (2010) Marco Auprich et al. EUROPEAN UROLOGY
- Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication
- (2010) Andrew Vickers et al. JOURNAL OF CLINICAL ONCOLOGY
- Short-term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study
- (2009) Roderick C.N. van den Bergh et al. BJU INTERNATIONAL
- Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of Diagnosis
- (2009) Matthew R. Cooperberg et al. JNCI-Journal of the National Cancer Institute
- Mortality Results from a Randomized Prostate-Cancer Screening Trial
- (2009) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer
- (2009) Daphne Hessels et al. PROSTATE
- A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
- (2008) Andrew J Vickers et al. BMC Medicine
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
- (2008) C. M. Sturgeon et al. CLINICAL CHEMISTRY
- Prostate Specific Antigen Working Group Guidelines on Prostate Specific Antigen Doubling Time
- (2008) Philip M. Arlen et al. JOURNAL OF UROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started